ne (4a and 4b), benzofuran-quinone (5a and 5b) and chromene-quinone (6a and 6b) of juglone based 1,4-naphthoquinones were synthesized by employing a three step protocol with the cyclisation of o-allyl phenol as the key step. The anticancer activity of the newly synthesized compounds was evaluated in vitro against seven human cancer cell lines including cervix (ME-180 and HeLa), breast (MCF-7, MDA-MB-453
六种新颖的5,6-融合杂化物,如二氢
苯并呋喃-醌(4a和4b),
苯并呋喃-醌(5a和5b)和
苯并呋喃醌(1a和6b)(基于朱古力的
1,4-萘醌)合成了三种步骤步骤,以邻烯丙基
苯酚环化为关键步骤。在体外评估了新合成化合物的抗癌活性可以通过以下方法抗7种人类癌
细胞系:宫颈(ME-180和HeLa),乳腺(MCF-7,
MDA-MB-453和
MDA-MB-231),前列腺癌(PC-3)和结肠癌(HT-29) M
TT测定。筛选结果表明,大多数合成的化合物均表现出显着的抗癌活性。特别地,化合物6a和6b分别显示出比标准药物
依托泊苷对前列腺和乳腺癌
细胞系有效的活性。流式细胞仪分析表明,化合物6a和6b分别诱导PC-3和
MDA-MB-453细胞凋亡,并使细胞周期停滞在G2 / M期。